Using cell therapy to revolutionise treatment of end-stage liver disease

End-stage liver disease is a cruel illness, compounded by the scarcity of donor livers needed to extend life.
In the latest edition of #OptimumTV with Resolution Therapeutics’ CEO Amir Hefni, learn how the University of Edinburgh spin-out is developing a pioneering non-surgical treatment for end-stage liver disease using autologous cell therapy.